JAZZ | Jazz Pharmaceuticals plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31
Revenue	3.83B	3.66B	3.09B	2.36B	2.16B	1.89B	1.62B	1.49B	1.32B	1.17B	872.42M	585.98M	272.28M	173.78M	128.45M	67.51M	65.30M	44.86M	21.44M	N/A
Cost of Revenue	435.58M	540.52M	440.76M	148.92M	127.93M	121.54M	110.19M	105.39M	102.53M	117.42M	102.15M	78.42M	13.94M	13.56M	9.64M	13.92M	8.90M	6.97M	4.29M	N/A
Gross Profit	3.40B	3.12B	2.65B	2.21B	2.03B	1.77B	1.51B	1.38B	1.22B	1.06B	770.28M	507.55M	258.33M	160.22M	118.81M	53.59M	56.40M	37.89M	17.15M	N/A
Operating Expenses	2.82B	2.61B	2.48B	1.45B	1.39B	1.11B	894.66M	767.18M	682.53M	617.88M	429.96M	309.71M	130.50M	102.43M	102.88M	194.19M	195.18M	115.94M	74.29M	-24.80M
Selling, General & Admin	1.34B	1.42B	1.45B	854.23M	736.94M	683.53M	544.16M	502.89M	449.12M	406.11M	304.30M	223.88M	108.94M	69.00M	58.65M	111.40M	78.54M	51.38M	23.55M	N/A
Research & Development	849.66M	590.45M	505.75M	335.38M	299.73M	226.62M	198.44M	162.30M	135.25M	85.18M	46.62M	20.48M	14.12M	25.61M	36.56M	69.96M	69.79M	54.96M	45.78M	N/A
Other Operating Expenses	627.28M	599.17M	525.77M	259.58M	354.81M	201.50M	152.06M	101.99M	98.16M	126.58M	79.04M	65.35M	7.45M	7.83M	7.67M	12.83M	46.85M	9.60M	4.96M	-24.80M
Operating Income	578.58M	512.27M	170.28M	765.46M	532.37M	614.84M	528.84M	591.65M	508.22M	195.59M	340.31M	197.84M	127.83M	57.79M	15.93M	-170.37M	-138.78M	-78.05M	-78.44M	-24.80M
Other Expenses / Income	-280.65M	-307.26M	-283.12M	-102.98M	-78.07M	-85.38M	-87.72M	-59.21M	-72.29M	-44.03M	-32.36M	-20.49M	-2.85M	-25.01M	-22.77M	-13.97M	-48.00K	18.66M	-28.01M	N/A
Before Tax Income	297.93M	-372.78M	-112.84M	275.10M	454.30M	529.46M	441.12M	532.45M	435.93M	151.56M	307.95M	177.35M	124.98M	32.78M	-6.84M	-184.34M	-138.83M	-47.57M	-100.64M	N/A
Income Tax Expenses	-119.91M	-158.65M	216.12M	33.52M	-73.15M	80.16M	-47.74M	135.24M	106.40M	94.23M	91.64M	-83.79M	2.85M	25.01M	22.77M	43.74M	48.00K	-18.66M	28.01M	24.80M
Net Income	414.83M	-214.14M	-328.95M	238.62M	523.37M	447.10M	487.85M	396.83M	329.54M	58.39M	216.31M	288.59M	124.98M	32.78M	-6.84M	-184.34M	-138.83M	-59.39M	-85.16M	-24.80M
Interest Expenses	289.44M	288.24M	278.77M	99.71M	72.26M	77.08M	77.76M	61.94M	56.92M	52.71M	26.92M	16.87M	1.68M	12.73M	22.80M	19.74M	N/A	N/A	N/A	N/A
Basic Shares Outstanding	63.29M	62.54M	59.69M	55.71M	56.75M	59.98M	60.02M	60.50M	61.23M	59.75M	58.30M	56.64M	41.50M	36.34M	30.02M	25.65M	13.83M	13.47M	13.47M	13.47M
Diluted Shares Outstanding	72.07M	62.54M	59.69M	56.52M	57.55M	61.22M	61.32M	61.87M	63.04M	62.61M	61.57M	60.20M	46.80M	39.41M	30.02M	25.65M	13.83M	13.47M	13.47M	13.47M
EBITDA	1.29B	553.78M	1.03B	649.65M	1.01B	932.66M	779.00M	753.88M	665.97M	583.70M	454.11M	268.45M	136.91M	54.22M	15.93M	-125.58M	-128.25M	-67.74M	-51.70M	-24.80M
EBITDA Margin	33.59%	15.13%	33.21%	27.49%	46.84%	49.32%	48.12%	50.67%	50.27%	49.77%	52.05%	45.81%	50.28%	31.20%	12.40%	-186.00%	-196.40%	-151.02%	-241.14%	0.00%
EBIT	584.36M	-84.54M	165.93M	371.84M	522.47M	604.34M	517.86M	594.01M	492.85M	205.33M	334.87M	221.66M	129.51M	70.52M	38.73M	-120.86M	-138.78M	-78.05M	-57.14M	N/A
EBIT Margin	15.24%	-2.31%	5.36%	15.73%	24.17%	31.96%	31.99%	39.92%	37.20%	17.51%	38.38%	37.83%	47.56%	40.58%	30.15%	-179.01%	-212.51%	-174.01%	-266.50%	0.00%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31